HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Dorfleutner Selected Research

AFAP 110

12/2007AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.
10/2007AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Dorfleutner Research Topics

Disease

10Infections
12/2020 - 12/2007
8Inflammation (Inflammations)
01/2017 - 12/2003
4Rheumatoid Arthritis
02/2017 - 03/2009
3Porcine Reproductive and Respiratory Syndrome (PRRS)
10/2015 - 07/2013
3Neoplasms (Cancer)
04/2006 - 05/2004
2Sepsis (Septicemia)
12/2020 - 01/2018
2Splenomegaly
12/2017 - 10/2015
2Lymphadenopathy
12/2017 - 10/2015
2Melanoma (Melanoma, Malignant)
01/2017 - 01/2010
2Autoimmune Diseases (Autoimmune Disease)
10/2015 - 04/2014
1Cryopyrin-Associated Periodic Syndromes
01/2022
1Endotoxemia
12/2020
1Septic Shock (Toxic Shock Syndrome)
01/2018
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2017
1Dysbiosis
01/2017
1Shock
01/2017
1Colitis
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017
1Autoimmune Lymphoproliferative Syndrome
10/2015
1Staphylococcal Infections
10/2015
1Virus Diseases (Viral Diseases)
04/2014
1Arthritis (Polyarthritis)
11/2012
1Breast Neoplasms (Breast Cancer)
12/2007
1Prostatic Neoplasms (Prostate Cancer)
10/2007
1Carcinoma (Carcinomatosis)
10/2007
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2007
1Neoplasm Metastasis (Metastasis)
12/2003

Drug/Important Bio-Agent (IBA)

14InflammasomesIBA
01/2022 - 12/2007
7Proteins (Proteins, Gene)FDA Link
09/2020 - 12/2007
5Interleukin-18 (Interleukin 18)IBA
09/2020 - 08/2015
4Pattern Recognition ReceptorsIBA
10/2015 - 01/2010
3InterleukinsIBA
09/2020 - 10/2016
3Thromboplastin (Tissue Factor)IBA
10/2004 - 12/2003
2CaspasesIBA
12/2020 - 10/2015
2DNA (Deoxyribonucleic Acid)IBA
12/2017 - 04/2014
2Caspase 8 (Caspase-8)IBA
10/2015 - 04/2006
2LigandsIBA
10/2015 - 08/2012
2NLR ProteinsIBA
10/2015 - 03/2009
2NucleotidesIBA
10/2015 - 01/2010
2Pathogen-Associated Molecular Pattern MoleculesIBA
08/2015 - 12/2013
2CytokinesIBA
05/2015 - 03/2009
2AFAP 110IBA
12/2007 - 10/2007
1Multiprotein ComplexesIBA
12/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2018
1oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA
01/2018
1Immunoglobulin G (IgG)IBA
12/2017
1AutoantibodiesIBA
12/2017
1Interferon Type IIBA
12/2017
1Interleukin-22 (IL-22)IBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Carrier Proteins (Binding Protein)IBA
01/2017
1Dextran SulfateIBA
01/2017
1Antimicrobial PeptidesIBA
01/2017
1DNA-Activated Protein KinaseIBA
01/2017
1Death Domain ReceptorsIBA
10/2015
1Anti-Bacterial Agents (Antibiotics)IBA
10/2015
1LipopeptidesIBA
10/2015
1Glycoproteins (Glycoprotein)IBA
11/2012
1Neutralizing AntibodiesIBA
11/2012
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2012
1Interleukin-17 (Interleukin 17)IBA
03/2009
1ChemokinesIBA
03/2009
1Caspase 1 (ICE Protease)IBA
03/2009
1ThrombinFDA Link
07/2004
1Peptide Hydrolases (Proteases)FDA Link
05/2004

Therapy/Procedure

1Therapeutics
01/2018
1Ligation
10/2015